← All stocks

Savara Inc

SVRA Net buying
CIK 0001160308 #2475 in the set updated 18 Sep 2026
Bought (120 mo)
$16.17M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.67M
$0.00 on a plan · $3.02M straight out of an exercise
Sold at will
$2.65M
26 of 35 sales
Net
+$10.50M
+$13.52M against sales at will

By person

28 insiders · 168 transactions
10.2×

Matthew Pauls holds 10.2 times base salary in stock. $6.75M of shares against $660.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Pauls last reported holding, valued at $5.68, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RAMSAY DAVID A
Director
$3.97M (72)
$121.22K (1)
+$3.85M
2,533,642
1.23%
$14.39M
+177,326%
Lowrance David L
Chief Financial Officer
$34.54K (3)
$2.84M (14) scheduled
−$2.81M
536,032
0.2609%
$3.05M
BASKETT FOREST
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Behbahani Ali
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Chang Carmen
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Florence Anthony A. Jr.
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Growth Equity Opportunities 17, LLC entity
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Makhzoumi Mohamad
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Mathers Edward T
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
SANDELL SCOTT D
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Walker Paul Edward
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
Yang Rick
10% owner
$1,000.00K (1)
+$1,000.00K
24,471,264
11.91%
$139.03M
+1.4%
PIKOVER YURI
Director
$901.10K (3)
+$901.10K
429,179
0.2089%
$2.44M
+55.8%
Jouhikainen Jaakko Taneli
See Remarks
$49.88K (1)
$761.77K (8)
−$711.90K
167,569
0.0816%
$952.01K
−25.5%
Elam Nevan C
Director
$442.29K (1) scheduled
−$442.29K
106,887
0.0520%
$607.26K
McCracken Joseph S
Director
$428.08K (4)
+$428.08K
302,644
0.1473%
$1.72M
+3,874%
Pauls Matthew
CHIEF EXECUTIVE OFFICER
$240.24K (11)
$576.73K (2)
−$336.49K
1,188,050
0.5782%
$6.75M
Hawkins Richard J
Director
$98.57K (1)
$304.19K (3) scheduled
−$205.62K
161,326
0.0785%
$916.54K
Neville Robert N
Chief Executive Officer
$398.18K (2)
$540.49K (5)
−$142.30K
498,028
0.2424%
$2.83M
+31.7%
Chowdhury Badrul A.
CHIEF MEDICAL OFFICER
$26.25K (1)
$77.87K (1)
−$51.62K
300,000
0.1460%
$1.70M
Pratt Raymond Dennis
Chief Medical Officer
$24.45K (2)
+$24.45K
340,050
0.1655%
$1.93M
McCabe Kathleen R.
Chief Legal Officer
519,232
0.2527%
$2.95M
−7.0%
Erickson Anne
Chief Business Officer
371,712
0.1809%
$2.11M
+5.0%
Lutz Robert Matthew
Chief Fin. & Operating Officer
328,977
0.1601%
$1.87M
Wasfi Yasmine
Chief Medical Officer
168,008
0.0818%
$954.50K
+8.4%
Parker Braden C.
Chief Commercial Officer
105,000
0.0511%
$596.54K
van Es-Johansson An
Director
102,500
0.0499%
$582.33K
Sun Ricky
Director
22,500
0.0110%
$127.83K
Insider
Date
Role
Action
Shares
Price
Amount
Lowrance David L
22 Jun 2026
Chief Financial Officer
Sold after exercise
394,528
$5.68
$2.24M
Elam Nevan C
28 Dec 2023
Director
Sold after exercise
93,843
$4.71
$442.29K
Hawkins Richard J
14 May 2019
Director
Sold after exercise
14,591
$11.07
$161.46K
Lowrance David L
2 May 2019
Chief Financial Officer
Sold after exercise
3,700
$10.82
$40.02K
Lowrance David L
1 May 2019
Chief Financial Officer
Sold after exercise
3,800
$10.76
$40.90K
Lowrance David L
8 Apr 2019
Chief Financial Officer
Sold after exercise
4,734
$9.04
$42.78K
Lowrance David L
5 Apr 2019
Chief Financial Officer
Sold after exercise
320
$9.00
$2.88K
Lowrance David L
4 Apr 2019
Chief Financial Officer
Sold after exercise
2,446
$9.00
$22.01K
Neville Robert N
11 Jun 2018
Chief Executive Officer
Sold after exercise
1,791
$12.01
$21.51K

What was left out

Form 4 filings counted 197
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 6,900,592
Sales filed before the plan box existed 20
History held since 23 Jan 2017